STM-434

N/A

Report date: 2022/11/25 17:30:19

Base Information

Drug NameSTM-434
Drug Alias NameSTM-434
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionActivin inhibitors
TargetsActivins
Therapy Area/IndicationsSolid tumoursEndometrial NeoplasmsFallopian Tube Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanta Maria Biotherapeutics Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursEndometrial NeoplasmsFallopian Tube Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A